Suppr超能文献

Inhibition of Mycobacterium tuberculosis pantothenate synthetase by analogues of the reaction intermediate.

作者信息

Ciulli Alessio, Scott Duncan E, Ando Michiyo, Reyes Fernando, Saldanha S Adrian, Tuck Kellie L, Chirgadze Dimitri Y, Blundell Tom L, Abell Chris

机构信息

University Chemical Laboratory, University of Cambridge, Lensfield Road, Cambridge CB21EW, UK.

出版信息

Chembiochem. 2008 Nov 3;9(16):2606-11. doi: 10.1002/cbic.200800437.

Abstract
摘要

相似文献

4
A novel inhibitor of Mycobacterium tuberculosis pantothenate synthetase.
J Biomol Screen. 2007 Feb;12(1):100-5. doi: 10.1177/1087057106296484. Epub 2006 Dec 14.
5
The design and synthesis of inhibitors of pantothenate synthetase.
Org Biomol Chem. 2006 Oct 7;4(19):3598-610. doi: 10.1039/b609482a. Epub 2006 Aug 30.
6
Optimization of Inhibitors of Mycobacterium tuberculosis Pantothenate Synthetase Based on Group Efficiency Analysis.
ChemMedChem. 2016 Jan 5;11(1):38-42. doi: 10.1002/cmdc.201500414. Epub 2015 Oct 21.
8
Reaction intermediate analogues as bisubstrate inhibitors of pantothenate synthetase.
Bioorg Med Chem. 2014 Mar 1;22(5):1726-35. doi: 10.1016/j.bmc.2014.01.017. Epub 2014 Jan 23.

引用本文的文献

1
Expanding FTMap for Fragment-Based Identification of Pharmacophore Regions in Ligand Binding Sites.
J Chem Inf Model. 2024 Mar 25;64(6):2084-2100. doi: 10.1021/acs.jcim.3c01969. Epub 2024 Mar 8.
2
: Pathogenesis and therapeutic targets.
MedComm (2020). 2023 Sep 4;4(5):e353. doi: 10.1002/mco2.353. eCollection 2023 Oct.
3
The pathogenic mechanism of Mycobacterium tuberculosis: implication for new drug development.
Mol Biomed. 2022 Dec 22;3(1):48. doi: 10.1186/s43556-022-00106-y.
4
Inhibitors of pantothenate synthetase of - a medicinal chemist perspective.
RSC Adv. 2020 Oct 7;10(61):37098-37115. doi: 10.1039/d0ra07398a.
5
Potential secondary metabolite from Indonesian Actinobacteria (InaCC A758) against .
Iran J Basic Med Sci. 2021 Aug;24(8):1058-1068. doi: 10.22038/ijbms.2021.56468.12601.
6
Targeting CoaBC through Chemical Inhibition of 4'-Phosphopantothenoyl-l-cysteine Synthetase (CoaB) Activity.
ACS Infect Dis. 2021 Jun 11;7(6):1666-1679. doi: 10.1021/acsinfecdis.0c00904. Epub 2021 May 3.
7
Vitamin in the Crosshairs: Targeting Pantothenate and Coenzyme A Biosynthesis for New Antituberculosis Agents.
Front Cell Infect Microbiol. 2020 Dec 15;10:605662. doi: 10.3389/fcimb.2020.605662. eCollection 2020.
8
Targeting adenylate-forming enzymes with designed sulfonyladenosine inhibitors.
J Antibiot (Tokyo). 2019 Jun;72(6):325-349. doi: 10.1038/s41429-019-0171-2. Epub 2019 Apr 15.
10
Design, synthesis, and biological evaluation of α-hydroxyacyl-AMS inhibitors of amino acid adenylation enzymes.
Bioorg Med Chem Lett. 2016 Nov 1;26(21):5340-5345. doi: 10.1016/j.bmcl.2016.09.027. Epub 2016 Sep 16.

本文引用的文献

2
Fragment-based approaches to enzyme inhibition.
Curr Opin Biotechnol. 2007 Dec;18(6):489-96. doi: 10.1016/j.copbio.2007.09.003. Epub 2007 Oct 24.
3
Identification of gene targets against dormant phase Mycobacterium tuberculosis infections.
BMC Infect Dis. 2007 Jul 26;7:84. doi: 10.1186/1471-2334-7-84.
4
Antitubercular nucleosides that inhibit siderophore biosynthesis: SAR of the glycosyl domain.
J Med Chem. 2006 Dec 28;49(26):7623-35. doi: 10.1021/jm061068d.
5
A novel inhibitor of Mycobacterium tuberculosis pantothenate synthetase.
J Biomol Screen. 2007 Feb;12(1):100-5. doi: 10.1177/1087057106296484. Epub 2006 Dec 14.
6
Innovative lead discovery strategies for tropical diseases.
Nat Rev Drug Discov. 2006 Nov;5(11):941-55. doi: 10.1038/nrd2144.
7
The design and synthesis of inhibitors of pantothenate synthetase.
Org Biomol Chem. 2006 Oct 7;4(19):3598-610. doi: 10.1039/b609482a. Epub 2006 Aug 30.
8
Novel targets for tuberculosis drug discovery.
Curr Opin Pharmacol. 2006 Oct;6(5):459-67. doi: 10.1016/j.coph.2006.06.004. Epub 2006 Aug 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验